Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Personalis, Inc. - Common Stock
(NQ:
PSNL
)
9.130
-1.150 (-11.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Recap: Personalis Q2 Earnings
August 04, 2021
Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 17.24% year over year to...
Via
Benzinga
Personalis Reports Second Quarter 2021 Financial Results
August 04, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
August 03, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
August 02, 2021
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For August 4, 2021
August 04, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...
Via
Benzinga
Personalis to Announce Second Quarter Financial Results on August 4, 2021
July 21, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces NeXT Level Biomarkers Symposium
June 22, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
June 02, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 18, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis, Inc. to Present at Biomarkers Week Online 2021
May 17, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Reports First Quarter 2021 Financial Results
May 05, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the 2021 Bank of America Healthcare Conference
April 29, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Report First Quarter 2021 Financial Results on May 5, 2021
April 21, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
April 08, 2021
From
Personalis, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today